| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $12.14M | $7.00M | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $116.71M | $146.71M | $132.28M | $123.54M | $113.73M |
| R&D | $94.30M | $118.00M | $103.39M | $92.89M | $86.78M |
| SG&A | $22.41M | $28.72M | $28.88M | $30.65M | $26.96M |
| Operating Income | -$104.57M | -$139.71M | -$132.28M | -$123.54M | -$113.73M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$99.50M | -$127.17M | -$121.83M | -$115.44M | -$111.69M |
| EPS (basic) | -1.2900 | -1.6800 | -2.0200 | -2.4400 | -2.4300 |
| EPS (diluted) | -1.2900 | -1.6800 | -2.0200 | -2.4400 | -2.4300 |
| Shares (diluted) | $76.96M | $75.81M | $60.36M | $47.37M | $46.05M |